Amplification of cyclin D1 gene in multiple myeloma: Clinical and prognostic relevance

British Journal of Haematology

Volumn 109, Issue 1, 2000, Pages 30-38

  Hoechtlen Vollmar, Wilma ^a,d   Menzel, Gabriele ^a   Bartl, Reiner ^b   Lamerz, Rolf ^c   Wick, Manfred ^a   Seidel, Dietrich ^a  

^a Klin Chem Inst   (Germany)

^b Med Dept III   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Amplification; Cyclin D1; Fluorescence in situ hybridization (FISH); Multiple myeloma; Prognostic factors

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CREATININE; CYCLIN D1;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL INFILTRATION; CELL SELECTION; CELL STRUCTURE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; IMMUNOBLOTTING; LABELING INDEX; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYCLIN D1; DISEASE-FREE SURVIVAL; GENE AMPLIFICATION; GENES, BCL-1; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; MULTIPLE MYELOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 0034034424     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02007.x     Document Type: Article

References (23)

1. Akervall, J.A., Michalides, R.J., Mineta, H., Balm, A., Borg, A., Dictor, M.R., Jin, Y., Loflus, B., Mertens, F. & Wennerberg, J.P. (1997) Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer, 79, 380-389.
2. Bartkova, J., Lukas. J., Strauss, M. & Bartek, J. (1994) Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. Journal of Pathology, 172, 237-245.
3. Bartl, R., Frisch, B., Diem, H., Mündel, M. & Fateh-Moghadam, A. (1989) Bone marrow histology and serum beta 2 microglobulin in multiple myeloma - a new prognostic strategy. European Journal of Haematology Supplement, 43, 88-98.
4. Buckley, M.F., Sweeney, K.J.E., Hamilton. J.A., Sini, R.L., Mamming, D.L., Nicholson, R.I., deFazio, A., Watts, C.K., Musgrove, E.A. & Sutherland, R.L. (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8, 2127-2133.
5. Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society, 34, 187-220.
6. Donnellan, R. & Chetty, R. (1998) Cyclin D1 and human neoplasia. Journal of Clinical Pathology: Molecular Pathology, 51, 1-7.
7. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer, 36, 842-854.
8. Fonseca, R., Witzig, T.E., Gertz, M.A., Kyle, R.A., Hoyer, J.D., Jalal, S.M. & Greipp, P.R. (1998) Multiple myeloma and the translocation t (11; 14) (q13; q32): a report on 13 cases. British Journal of Haematology, 101, 296-301.
9. Greipp. P.R., Lust, J.A., O'Fallon, M., Katzmann, J.A., Witzig, T.E. & Kyle, R.A. (1993) Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood, 81, 3282-3387.
10. Kaplan, E. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-485.
11. Kawano, M.M., Mahmoud, M.S. & Ishikawa, H. (1997) Cyclin D1 and p16INK4A are preferentially expressed in immature and mature myeloma cells, respectively. British Journal of Haematology, 99, 131-138.
12. Lai, R., Medeiros. L.J., Wilson, C.S., Sun, X.C., Koo, C., McCourty, A. & Brynes, R.K. (1998) Expression of the cell-cycle-related proteins E2F-1, p53, mdm-2, p21waf-1, and Ki-67 in multiple myeloma: correlation wilh cyclin D1 immunoreactivity. Modern Pathology, 11, 642-647.
13. Lebwohl, D.E., Muise-Helmericks, R., Sepp-Lorenzino, L., Serve, S., Timaul, M., Bol, R., Borgen, P. & Rosen, N. (1994) A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene, 9, 1925-1929.
14. McIntosh, G.G., Anderson. J.J., Milton, I., Steward, M., Parr, A.H., Thomas, M.D., Henry. J.A., Angus, B., Lennard, T.W.J. & Horne, C.H.W. (1995) Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene, 11, 885-891.
15. Nishida, K., Tamura, A., Nakazawa, N., Ueda, Y., Ade, T., Matsuda, F., Kashima, K. & Taniwaki, M. (1997) The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood, 90, 526-534.
16. Segal, G.H., Masih, A.S., Canavan Fox, A., Jorgensen, T., Scott, M. & Braylan, P.C. (1995) CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Blood, 85, 1570-1579.
17. Sheyn, I., Noffsinger, A.E., Heffelfinger, S., Davis, B., Miller, M.A. & Fenoglio-Preiser, C.M. (1997) Amplification and expression of cyclin D1 gene in anal and esophageal squamous cell carcinomas. Human Pathology, 28, 270-276.
18. Shimazaki, C., Goto, H., Araki, S., Tatsumi, T., Takahashi, R., Hirai, H., Kihuta, T., Yamagata, N., Ashihara, E., Inaba, T., Fujita, N., Suzuki, R. & Nakagawa, M. (1997) Overexpression of PRAD1/ cyclin D1 in plasma cell leukemia with t (11: 14) (q13: q32) International Journal of Hematology, 66, 111-115.
19. Sonoki, T., Nakazawa, N., Hata, H., Taniwaki, M., Nagasaki, A., Seto, M., Yoshida, M., Kuribayashi, N., Kimura, T., Harada, N., Mitsuya, H. & Matsuzaki, H. (1998) Amplification and overexpression of PRAD1/cyclin D1 gene in a multiple myeloma cell line. International Journal of Hematology, 68, 459-461.
20. Sonoki, T., Hata, H., Kuribayashi, N., Yoshida, M., Harada, N., Nagasaki, A., Kimura, T., Matsuno, F., Mitsuya, H. & Matsuzaki, H. (1999) Expression of PRAD1/cyclin D1 plasma cell malignancy: incidence and prognostic aspects. British Journal of Haematolugy, 104, 614-617.
21. Taniguchi, T., Fujita, A., Takahashi, S., Uchimaru, K., Yoshikawa, M., Asano, S., Fujita, T. & Motokura, T. (1998) Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies. Japanese Journal of Cancer Research, 89, 159-166.
22. Tricot, G., Barlogie, B., Jagannath, S., Bracy, D., Mattox, S., Vesole, D.H., Nauke, S. & Sawyer, J.R. (1995) Poor prognosis in multiple myeloma is associated only with partial and complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood, 86, 4250-4256.
23. Vasef, M.A., Madeiros, L.J., Yospur, L.S., Sun. N.C., McCourty, A. & Brynes, R.K. (1997) Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin embedded tissue sections. Modern Pathology. 10, 927-932.